seed
Stage
About
Crosslink Therapeutics develops modular biologic therapeutics that conditionally assemble in the tumor microenvironment by leveraging elevated extracellular ATP in solid tumors to improve targeting and efficacy in cancer treatment.
Explore Crosslink Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.